Year Ended December 31,

2016

2015

Cash paid for interest

$

1,441,160

$

624,896

Cash paid for income taxes

$

157,346

$

1,386,955

Non-cash investing and financing activities:

Accrued liabilities settled through the issuance of common stock and warrants

$

2,231,829

$

–

Exercise of stock options as reduction of notes payable, related party

$

–

$

2,500,000

Adjustment of goodwill

$

–

$

131,270

Assets acquired through capital leases

$

–

$

1,638,884

Acquisition of noncontrolling interest in Biohealth Medical Laboratory, Inc.

$

259,875

Acquisition of CollabRx

$

–

$

13,510,777

Conversions of preferred stock into common stock

$

37,823,000

$

25